Brigatinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the bodys. Brigatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.Brigatinib Nitroso Impurity 2is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brigatinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl) phenyl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brigatinib Nitroso Impurity 2 . We supply Brigatinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014534 |
| CAS No | NA |
| Mol.F. | C22H17FN8O2 |
| Mol.Wt. | 444.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014535 |
| CAS No | NA |
| Mol.F. | C19H17N5O3S |
| Mol.Wt. | 395.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014536 |
| CAS No | NA |
| Mol.F. | C19H19N7O2 |
| Mol.Wt. | 377.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014537 |
| CAS No | NA |
| Mol.F. | C19H18N8O3 |
| Mol.Wt. | 406.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014538 |
| CAS No | NA |
| Mol.F. | C8H5N3O3 |
| Mol.Wt. | 191.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014539 |
| CAS No | NA |
| Mol.F. | C49H53N9O9 |
| Mol.Wt. | 912.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014540 |
| CAS No | NA |
| Mol.F. | C49H52N10O10 |
| Mol.Wt. | 941.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014541 |
| CAS No | NA |
| Mol.F. | C49H53N9O9 |
| Mol.Wt. | 912.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014542 |
| CAS No | NA |
| Mol.F. | C45H49ClN8O8S |
| Mol.Wt. | 897.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014543 |
| CAS No | NA |
| Mol.F. | C45H48ClN9O9S |
| Mol.Wt. | 926.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014544 |
| CAS No | NA |
| Mol.F. | C45H49ClN8O8S |
| Mol.Wt. | 897.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014545 |
| CAS No | NA |
| Mol.F. | C26H26N6O3 |
| Mol.Wt. | 470.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014546 |
| CAS No | NA |
| Mol.F. | C17H18F3N7O2 |
| Mol.Wt. | 409.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014547 |
| CAS No | NA |
| Mol.F. | C20H18F2N4O4 |
| Mol.Wt. | 416.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014548 |
| CAS No | 3085658-79-0 |
| Mol.F. | C24H32Cl2N2O6 |
| Mol.Wt. | 515.4 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014549 |
| CAS No | NA |
| Mol.F. | C16H23N3O |
| Mol.Wt. | 273.4 |
| INV STATUS | In Stock |